Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Directorate Change

29 Nov 2023 07:01

RNS Number : 9803U
Benchmark Holdings PLC
29 November 2023
 

29 November 2023

 

Benchmark Holdings plc

("Benchmark" or the "Company")

Directorate Change

The Company is pleased to announce the appointment of Jonathan Esfandi as Non-Executive Director. Mr Esfandi is the founder and managing partner at JNE Partners LLP. 

Mr. Esfandi will act as shareholder representative of JNE Partners LLP, a significant shareholder of the Company, and therefore the Board has concluded that he is not an independent director. 

Laura Lavers, who joined the Board in November 2022, will retire from the Board as a Non-Executive Director with effect from today.

 

Peter George, Chairman, commented:

"We welcome Jonathan to the Board and look forward to working together. On behalf of the Board, I wish to thank Laura Lavers for her contribution over the past year."

The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with the appointment of Jonathan to the Board of the Company:

Full Name: Jonathan Esfandi

Age: 49

Current Directorships: 

JNE PARTNERS LLP

JNE PARTNERS (UK) SERVICES LTD

Former Directorships (previous five years): None within the past five years

Beneficial interest in the equity securities of Benchmark Holdings plc: No direct beneficial interest. Funds managed by JNE Partners LLP have a holding of 169,263,811 shares in Benchmark

There is no further information required to be disclosed under Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Enquiries

For further information, please contact:

Benchmark Holdings plc

Tel: 0114 240 9939

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Deutsche Numis (Nominated Adviser and Broker)

Tel: 020 7260 1000

Freddie Barnfield, Duncan Monteith, Sher Shah

MHP

Tel: 020 3128 8004

Katie Hunt, Reg Hoare

benchmark@mhpgroup.com

 

Equity Development

Hannah Crowe

 

Tel: 020 7065 2692

 

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADXBDBXGDDGXI
Date   Source Headline
12th Aug 20197:00 amRNSQ3 Trading Update
31st Jul 20191:15 pmRNSReplacement: Total Voting Rights
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20197:00 amRNSGenetics Breakthrough in Tilapia
9th Jul 20197:00 amRNSDirectorate Change
2nd Jul 20193:49 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSHolding(s) in Company
28th Jun 20194:41 pmRNSSecond Price Monitoring Extn
28th Jun 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20192:05 pmRNSSecond Price Monitoring Extn
28th Jun 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSInterim Results
13th Jun 20198:00 amRNSPlacement of a new senior secured bond issue
10th Jun 20197:00 amRNSUpdate on Joint Venture with AquaChile
3rd Jun 20197:00 amRNSTrading Update and Investor Meetings
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSUpdate on Joint Venture with AquaChile
30th Apr 20197:00 amRNSTotal Voting Rights
29th Mar 20192:25 pmRNSReplacement: Total Voting Rights
29th Mar 20197:00 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Mar 201912:21 pmRNSResult of AGM
28th Feb 20197:00 amRNSTotal Voting Rights
20th Feb 20197:00 amRNSAppointment of Non-Executive Director
29th Jan 20193:07 pmRNSPosting of Annual Report & Notice of AGM
28th Jan 20198:00 amRNSDIRECTOR SHARE OPTIONS
24th Jan 20197:00 amRNSFull Year Results
14th Jan 20197:00 amRNSNotice of Results
31st Dec 20188:00 amRNSTotal Voting Rights
12th Dec 20183:08 pmRNSDirector/PDMR Shareholding
12th Dec 201811:01 amRNSHolding(s) in Company
10th Dec 20185:05 pmRNSHolding(s) in Company
7th Dec 20183:35 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
30th Nov 20187:00 amRNSTotal Voting Rights
27th Nov 20187:00 amRNSSuccessful defence of patent infringement in Asia
7th Nov 20187:00 amRNSTrading Statement
31st Oct 20187:00 amRNSTotal Voting Rights
23rd Oct 20184:55 pmRNSHolding(s) in Company
22nd Oct 20185:52 pmRNSHolding(s) in Company
10th Oct 20182:53 pmRNSDIRECTOR DEALINGS
3rd Oct 20187:00 amRNSAcquisition and Issue of Equity
2nd Oct 20187:00 amRNSAppointment of Chief Scientific Officer
28th Sep 20187:00 amRNSTotal Voting Rights
21st Sep 20187:00 amRNSBlock listing Interim Review
12th Sep 20187:00 amRNSBlock Admission Application
10th Sep 20187:00 amRNSCommencement of salmon egg production in Salten
30th Aug 20187:00 amRNSTotal Voting Rights
30th Jul 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.